{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:11:30Z","timestamp":1792131090813,"version":"4.4.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["CUP E53D23011330006"],"award-info":[{"award-number":["CUP E53D23011330006"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.nbd.2026.107430","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:44:16Z","timestamp":1777578256000},"page":"107430","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Elevated plasma sTREM2 reflects microglial activation but lacks diagnostic and clinical relevance in amyotrophic lateral sclerosis"],"prefix":"10.1016","volume":"224","author":[{"given":"Gianmaria","family":"Senerchia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina Virginia","family":"Iuzzolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Spisto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Panico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Polito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Aruta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Fiorenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Sirica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Terracciano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Dubbioso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2026.107430_bb0005","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-57144-7","article-title":"Phosphorylated tau 181 and 217 are elevated in serum and muscle of patients with amyotrophic lateral sclerosis","volume":"16","author":"Abu-Rumeileh","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2026.107430_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(18)30394-6","article-title":"Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies","author":"Beers","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2026.107430_bb0015","first-page":"293","article-title":"El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis","volume":"1","author":"Brooks","year":"2000","journal-title":"Amyotroph. Lateral Scler."},{"key":"10.1016\/j.nbd.2026.107430_bb0020","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1001\/jamaneurol.2013.6237","article-title":"TREM2 variant p.R47H as a risk factor for sporadic amyotrophic lateral sclerosis","volume":"71","author":"Cady","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.nbd.2026.107430_bb0025","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0022-510X(99)00210-5","article-title":"The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function","volume":"169","author":"Cedarbaum","year":"1999","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2026.107430_bb0030","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/jnnp.2010.235952","article-title":"Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study","volume":"82","author":"Chio","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2026.107430_bb0035","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40478-017-0424-x","article-title":"A data-driven approach links microglia to pathology and prognosis in amyotrophic lateral sclerosis","volume":"5","author":"Cooper-Knock","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.nbd.2026.107430_bb0040","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.cell.2020.05.003","article-title":"The physiology, pathology, and potential therapeutic applications of the TREM2 signaling pathway","volume":"181","author":"Deczkowska","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2026.107430_bb0045","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-022-02443-9","article-title":"CSF sTREM2 in neurological diseases: a two-sample Mendelian randomization study","volume":"19","author":"Dong","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.nbd.2026.107430_bb0050","doi-asserted-by":"crossref","DOI":"10.1038\/s41597-024-03597-2","article-title":"Voice signals database of ALS patients with different dysarthria severity and healthy controls","volume":"11","author":"Dubbioso","year":"2024","journal-title":"Sci. Data"},{"key":"10.1016\/j.nbd.2026.107430_bb0055","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0140-6736(22)01272-7","article-title":"Amyotrophic lateral sclerosis","volume":"400","author":"Feldman","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2026.107430_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2017.00242","article-title":"The dual role of microglia in ALS: mechanisms and therapeutic approaches","volume":"9","author":"Geloso","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.nbd.2026.107430_bb0065","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/acn3.51853","article-title":"The role of peripheral immunity in ALS: a population-based study","volume":"10","author":"Grassano","year":"2023","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.nbd.2026.107430_bb0070","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13024-016-0071-x","article-title":"Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer\u2019s disease","volume":"11","author":"Heslegrave","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2026.107430_bb0075","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1002\/acn3.51078","article-title":"Longitudinal biomarkers in amyotrophic lateral sclerosis","volume":"7","author":"Huang","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.nbd.2026.107430_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbi.2023.01.013","article-title":"Profiling TREM2 expression in amyotrophic lateral sclerosis","author":"Jeric\u00f3","year":"2023","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.nbd.2026.107430_bb0085","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1515252","article-title":"sTREM2 cerebrospinal fluid levels are a potential biomarker in amyotrophic lateral sclerosis and associate with UMN burden","volume":"15","author":"Jiao","year":"2024","journal-title":"Front. Neurol."},{"key":"10.1016\/j.nbd.2026.107430_bb0090","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1212\/01.wnl.0000194316.91908.8a","article-title":"Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS","volume":"66","author":"Kimura","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2026.107430_bb0095","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000213400","article-title":"Comparative performances of 4 serum NfL assays, pTau181, and GFAP in patients with amyotrophic lateral sclerosis","volume":"104","author":"Mondesert","year":"2025","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2026.107430_bb0100","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1474-4422(11)70015-1","article-title":"Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease","volume":"10","author":"Philips","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2026.107430_bb0105","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1002\/mus.26764","article-title":"Reliable and efficient scale to assess upper motor neuron disease burden in amyotrophic lateral sclerosis","volume":"61","author":"Quinn","year":"2020","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nbd.2026.107430_bb0110","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/brain\/awr351","article-title":"A proposed staging system for amyotrophic lateral sclerosis","volume":"135","author":"Roche","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2026.107430_bib146","doi-asserted-by":"crossref","first-page":"107415","DOI":"10.1016\/j.nbd.2026.107415","article-title":"Plasma NfL, GFAP and pTau181 define distinct biological axes in amyotrophic lateral sclerosis","volume":"224","author":"Senerchia","year":"2026","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2026.107430_bb0115","doi-asserted-by":"crossref","DOI":"10.1111\/ene.70171","article-title":"Identifying mild behavioral and neurocognitive impairment in amyotrophic lateral sclerosis (MBNI-ALS) provides key prognostic insights","volume":"32","author":"Spisto","year":"2025","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.nbd.2026.107430_bb0120","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/21678421.2016.1267768","article-title":"Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): revised diagnostic criteria","volume":"18","author":"Strong","year":"2017","journal-title":"Amyotroph. Lateral Scler. Frontotemp. Degener."},{"key":"10.1016\/j.nbd.2026.107430_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-018-0301-5","article-title":"Early increase of CSF sTREM2 in Alzheimer\u2019s disease is associated with tau related-neurodegeneration but not with amyloid-\u03b2 pathology","volume":"14","author":"Su\u00e1rez-Calvet","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2026.107430_bb0130","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/s41582-018-0072-1","article-title":"TREM2 \u2014 a key player in microglial biology and Alzheimer disease","volume":"14","author":"Ulland","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.nbd.2026.107430_bb0135","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/WCO.0000000000001411","article-title":"Neurochemical biomarkers of amyotrophic lateral sclerosis: recent developments","volume":"38","author":"Verde","year":"2025","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.nbd.2026.107430_bb0140","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/jnnp-2018-318704","article-title":"Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis","volume":"90","author":"Verde","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2026.107430_bb0145","doi-asserted-by":"crossref","DOI":"10.1002\/dneu.22864","article-title":"Microglial TREM2 in Amyotrophic Lateral Sclerosis","author":"Xie","year":"2022","journal-title":"Dev. Neurobiol."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996126001750?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996126001750?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T11:30:29Z","timestamp":1785151829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996126001750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":30,"alternative-id":["S0969996126001750"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2026.107430","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated plasma sTREM2 reflects microglial activation but lacks diagnostic and clinical relevance in amyotrophic lateral sclerosis","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2026.107430","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107430"}}